These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12580943)

  • 1. Molecular analysis of the 21-hydroxylase gene.
    Belgorosky A; Marino R; Rivarola M
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):247. PubMed ID: 12580943
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro gene amplification for prenatal diagnosis of congenital adrenal hyperplasia.
    Rumsby G; Honour JW
    J Med Genet; 1990 Nov; 27(11):676-8. PubMed ID: 2277381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital adrenal hyperplasia.
    Wedell A
    Clin Biochem; 2011 May; 44(7):505-506. PubMed ID: 22036349
    [No Abstract]   [Full Text] [Related]  

  • 4. An overview of molecular diagnosis of steroid 21-hydroxylase deficiency.
    Keegan CE; Killeen AA
    J Mol Diagn; 2001 May; 3(2):49-54. PubMed ID: 11393164
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments to “A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency”.
    Concolino P; Mello E; Rossodivita A; Giardina B; Capoluongo E
    Gene; 2014 Jan; 534(2):449-450. PubMed ID: 24501745
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments to "a rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency".
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2014 Jan; 534(2):451-2. PubMed ID: 24100083
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic analysis does not confirm non-classical congenital adrenal hyperplasia in more than a third of the women followed with this diagnosis.
    Alcantara-Aragon V; Martinez-Couselo S; Tundidor-Rengel D; Webb SM; Carreras G; Espinos JM; Chico A; Blanco-Vaca F; Corcoy R
    Hormones (Athens); 2014; 13(4):585-7. PubMed ID: 25402394
    [No Abstract]   [Full Text] [Related]  

  • 8. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
    Speiser PW; White PC
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):411-7. PubMed ID: 9876336
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: molecular analysis of congenital adrenal hyperplasia in a newborn screening program.
    Killeen AA
    Mol Diagn; 2001 Sep; 6(3):189-91. PubMed ID: 11571712
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency.
    Gonçalves J; Friães A; Moura L
    Expert Rev Mol Med; 2007 Apr; 9(11):1-23. PubMed ID: 17466088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analytical strategy for mutation screening in 21-hydroxylase deficiency.
    Krone N; Roscher AA; Schwarz HP; Braun A
    Clin Chem; 1998 Oct; 44(10):2075-82. PubMed ID: 9761237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular analysis of 21-hydroxylase gene of simple-virilizing 21-hydroxylase deficiency].
    Ogo A; Haji M; Nawata H; Kono H
    Fukuoka Igaku Zasshi; 1988 Nov; 79(11):787-90. PubMed ID: 3266936
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple tumors associated with late-onset congenital adrenal hyperplasia due to aberrant splicing of adrenal 21-hydroxylase gene.
    Boos CJ; Rumsby G; Matfin G
    Endocr Pract; 2002; 8(6):470-3. PubMed ID: 15251833
    [No Abstract]   [Full Text] [Related]  

  • 14. E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kirby-Keyser L; Porter CC; Donohoue PA
    Hum Mutat; 1997; 9(2):181-2. PubMed ID: 9067760
    [No Abstract]   [Full Text] [Related]  

  • 15. The molecular genetics of 21-hydroxylase deficiency.
    Miller WL; Morel Y
    Annu Rev Genet; 1989; 23():371-93. PubMed ID: 2694937
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiplex ligation-dependent probe amplification analysis is useful for diagnosing congenital adrenal hyperplasia but requires a deep knowledge of CYP21A2 genetics.
    Concolino P; Mello E; Minucci A; Zuppi C; Capoluongo E
    Clin Chem; 2011 Jul; 57(7):1079-80. PubMed ID: 21507910
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of time in assessing the effectiveness of newborn screening for congenital adrenal hyperplasia.
    Tarini BA
    JAMA Pediatr; 2014 Jun; 168(6):515-6. PubMed ID: 24733500
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia.
    Wedell A
    Clin Lab Med; 1996 Mar; 16(1):125-37. PubMed ID: 8867587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital adrenal hyperplasia--a continuum of disorders.
    Hughes IA
    Lancet; 1998 Sep; 352(9130):752-4. PubMed ID: 9737273
    [No Abstract]   [Full Text] [Related]  

  • 20. Congenital adrenal hyperplasia: diagnostic advances.
    Torresani T; Biason-Lauber A
    J Inherit Metab Dis; 2007 Aug; 30(4):563-75. PubMed ID: 17694353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.